Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.32 HKD | -3.03% | -1.54% | -48.39% |
Apr. 12 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
Apr. 08 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-48.39% | 54.62M | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+2.97% | 22.19B | |
-16.16% | 21.33B | |
-7.10% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- 2197 Stock
- News Clover Biopharmaceuticals, Ltd.
- Clover Bio's COVID Vaccine Candidate to Begin Phase 2 Clinical Trial as Booster Dose